RETROSPECTIVE ANALYSIS OF ANESTHETIC APPROACHES IN CESAREAN DELIVERIES INVOLVING PLACENTAL ANOMALIES
DOI:
https://doi.org/10.22159/ijcpr.2025v17i2.6035Keywords:
Placenta previa, Placenta accreta spectrum, Cesarean section, Anesthetic techniques, Obstetric haemorrhageAbstract
Objective: Placental anomalies such as placenta previa and placenta accreta spectrum disorders pose significant challenges during cesarean deliveries due to the increased risk of massive obstetric hemorrhage. Optimal anesthetic management is crucial to enhance maternal and fetal outcomes in these high-risk situations.
Methods: A retrospective observational study was conducted at Gulbarga Institute of Medical Sciences, Kalaburagi, from January 2023 to January 2024. Sixty pregnant women diagnosed with placental anomalies were divided into two groups: Group P (n = 42) with placenta previa and Group A (n = 18) with placenta accreta spectrum disorders. Data on demographics, anesthetic techniques, intraoperative parameters, and postoperative outcomes were collected and analyzed using statistical methods appropriate for continuous and categorical variables.
Results: General anaesthesiology was administered more frequently in group a (96.4%) compared to group p (74.6%) (p = 0.009). Group A had a significantly longer duration of surgery s (80.53±26.02 min vs. 52.43±13.34 min, p < 0.001) and greater estimated blood loss (1582.14±790.71 ml vs. 685.82±262.82 ml, p < 0.001). They also required more blood transfusions and had longer durations of mechanical ventilation (75.14±43.84 hours vs. 4.74±20.78 hours, p < 0.001) and ICU stays (2.80±1.13 days vs. 0.50±1.10 days, p < 0.001).
Conclusion: Patients with placenta accreta spectrum disorders face higher intraoperative and postoperative risks compared to those with placenta previa. General anaesthesiology is often preferred in these cases due to the potential for massive hemorrhage. Individualized anesthetic plans are essential to manage the increased perioperative challenges effectively.
Downloads
References
Betran AP, YE J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR. The increasing trend in caesarean section rates: global regional and national estimates: 1990-2014. Plos One. 2016;11(2):e0148343. doi: 10.1371/journal.pone.0148343, PMID 26849801.
Jauniaux E, Chantraine F, Silver RM, Langhoff Roos J, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265-73. doi: 10.1002/ijgo.12407, PMID 29405321.
Silver RM, Barbour KD. Placenta accreta spectrum: accreta increta and percreta. Obstet Gynecol Clin North Am. 2015;42(2):381-402. doi: 10.1016/j.ogc.2015.01.014, PMID 26002174.
Traynor AJ, Aragon M, Ghosh D, Choi RS, Dingmann C, VU Tran ZV. Obstetric anesthesia workforce survey: a 30 y update. Anesth Analg. 2016;122(6):1939-46. doi: 10.1213/ANE.0000000000001204, PMID 27088993.
Oppenheimer L, Maternal Fetal Medicine Committee. Retired: diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007;29(3):261-6. doi: 10.1016/S1701-2163(16)32401-X, PMID 17346497.
Publications Committee, Society for Maternal-Fetal Medicine, Belfort, MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430-9. doi: 10.1016/j.ajog.2010.09.013, PMID 21055510.
WU S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458-61. doi: 10.1016/j.ajog.2004.12.074, PMID 15902137.
Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275-84. doi: 10.1097/ACO.0000000000000180, PMID 25812005.
Gilsanz F, O Brien BM. Anesthetic considerations for placenta accreta. Anesthesiol Clin. 2017;35(3):607-23.
Mankowitz SK, Gonzalez Fiol A, Smiley RM. Anesthetic considerations for placenta accreta spectrum. Anesthesiology. 2019;131(1):191-208.
Bailit JL, Grobman WA, Rice MM, Spong CY, Wapner RJ, Varner MW. Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals. Am J Obstet Gynecol. 2013;209(5):446.e1-446.e30. doi: 10.1016/j.ajog.2013.07.019, PMID 23891630.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta increta and percreta in the UK: a population-based descriptive study. BJOG. 2014;121(1):62-70. doi: 10.1111/1471-0528.12405, PMID 23924326.
Allen L, Jauniaux E, Hobson S, Papillon Smith J, Belfort MA. Diagnosis and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can. 2019;41(7):1035-49.
Published
How to Cite
Issue
Section
Copyright (c) 2025 SUMANGALA MULAGUND, ANUSHA DHAGE, ASWIN M. S.

This work is licensed under a Creative Commons Attribution 4.0 International License.